Filing Details

Accession Number:
0000899243-20-032703
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-03 19:54:58
Reporting Period:
2020-12-01
Accepted Time:
2020-12-03 19:54:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1403752 Zymeworks Inc. ZYME Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1563992 Diana Hausman C/O Zymeworks Inc.
1385 West 8Th Avenue, Suite 540
Vancouver A1 V6H 3V9
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2020-12-01 4,122 $9.82 7,840 No 4 M Direct
Common Shares Acquisiton 2020-12-01 14,145 $11.84 21,985 No 4 M Direct
Common Shares Disposition 2020-12-01 18,267 $55.19 3,718 No 4 S Direct
Common Shares Acquisiton 2020-12-02 127 $9.82 3,845 No 4 M Direct
Common Shares Acquisiton 2020-12-02 574 $11.84 4,419 No 4 M Direct
Common Shares Disposition 2020-12-02 701 $55.01 3,718 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Stock Option (Right to Buy) Disposition 2020-12-01 4,122 $0.00 4,122 $9.82
Common Shares Stock Option (Right to Buy) Disposition 2020-12-01 14,145 $0.00 14,145 $11.84
Common Shares Stock Option (Right to Buy) Disposition 2020-12-02 127 $0.00 127 $9.82
Common Shares Stock Option (Right to Buy) Disposition 2020-12-02 574 $0.00 574 $11.84
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
70,878 2018-06-12 2027-06-12 No 4 M Direct
50,855 2019-03-19 2028-03-18 No 4 M Direct
70,751 2018-06-12 2027-06-12 No 4 M Direct
50,281 2019-03-19 2028-03-18 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 2,000 Indirect Held by spouse
Footnotes
  1. Pursuant to a 10b5-1 plan.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.00 to $55.67, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 1, 2020 at each separate price.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.00 to $55.05, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 2, 2020 at each separate price.
  4. Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following the first anniversary of grant date. The grant date was ten years before the listed expiration date.